Insider Cluster (2 insiders) ·Filed Sep 14, 2026

LIVN

LivaNova PLC
NEUTRAL
Impact 2/10
Horizondays Processed17d 23h ago
Insider cluster: 2 insiders, $460K total
Actionable Insight • Neutral

This cluster is too small to be informative. Monitor for any upcoming earnings or regulatory catalysts, but no immediate action is warranted based on these sales alone.

DirectionNeutral
Confidencehigh
Horizondays
Latest settled — T+5d
LIVN ▼ -1.23% at T+5d
NEUTRAL call ✗ call lost -1.23% · α vs SPY -3.34% · entry $79.47 → $78.49
Next anchor: T+20d in 10d
Latest observation: T+10 +3.76% FF3 residual α
Entry anchored
Sep 14, 04:00 PM ET
via 1-min bar
T+1d
-1.21%
call -1.21% · α -0.77%
$78.51
settled 17d ago
T+5d
-1.23%
call -1.23% · α -3.34%
$78.49
settled 11d ago
T+20d
—
call — · α —
—
in 10d
T+60d
—
call — · α —
—
in 2mo

Price Chart

Loading chart...

Executive Summary

Two LivaNova directors sold a combined $460K in open-market sales over a one-week window, with Bianchi Francesco selling $273K at $78.01 and Brooke Story selling $187K at $81.42. The total value is only ~0.01% of LIVN's $4.3B market cap, making this a trivial insider cluster with no material signal. The sales are likely routine portfolio diversification, not a bearish indicator, especially given the company's 81% bullish analyst consensus and strong historical performance of prior reports on this ticker (+4.74% avg T+20 P&L). Monitor for any upcoming earnings or regulatory catalysts, but this cluster alone does not warrant action.

Key Financial Metrics

Direction
selling
Total Value
$460.0K
Insiders
2

Key Facts

  • Two directors sold a total of $460K in open-market sales (Bianchi: $273K at $78.01; Story: $187K at $81.42)
  • Total sales represent ~0.01% of LIVN's $4.3B market cap, far below the 0.1% materiality threshold
  • No C-suite executives participated; only non-executive directors sold
  • LIVN has 81% bullish analyst consensus (6 Strong Buy, 7 Buy, 3 Hold)

Financial Impact

Total insider sales of $460K, or ~0.01% of market cap

insider_sales

Risk Factors

  • Insider sales could precede a negative catalyst, but the dollar amount is too small to be predictive
  • No C-suite participation reduces the signal value of the cluster

Market Snapshot

Exchange
Nasdaq
Sector
Electromedical & Electrotherapeutic Apparatus
Analyst Consensus
81% bullish (16 analysts)

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-LIVN-1789419952644
5 reports for LIVN
Performance horizon
100% Hit rate 3 of 3 directional calls best @ T+60▲ +20.95%May 6, 2026
Filters
Rows
Reports for LIVN — sortable, filterable
TypeNow
Sep 14, 2026
18d ago
Insider Cluster
NEUTRAL ★ 2/10
$79.47 $78.49▼ −1.23%▼ −3.34%$75.07 (−5.54%)
Aug 5, 2026
8w ago
8-K
BULLISH ★ 7/10
$78.15 $80.78▲ +3.37%▲ +3.02%$75.07 (−3.93%)
May 6, 2026
21w ago
8-K
BULLISH ★ 8/10
$66.26 $71.75▲ +8.29%▲ +7.15%$75.07 (+13.30%)
Apr 29, 2026
22w ago
DEFA14A
NEUTRAL ★ 2/10
$58.92 $66.26▲ +12.46%▲ +9.35%$75.07 (+27.41%)
Feb 25, 2026
31w ago
8-K
BULLISH ★ 7/10
$70.29 $65.26▼ −7.16%▼ −6.06%$75.07 (+6.80%)
Showing 5 of 5

US Market Status

Market Closed — Opens Mon (64h 37m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access
Report published Sep 14, 2026